The spit of fland of gas of A increases breast cancer patient's heart and declines the risk

The spit of fland of gas of A increases breast cancer patient's heart and declines the risk
The spit of fland of gas of A increases breast cancer patient's heart and declines the risk
Washington, January 4 (Xinhua) ' Reporter Ren HaiJun) A report that American researchers announced on the 4th says, it is accepted that the breast cancer patient suffers from the depleted risk of heart and is higher than the persons who have not adopted treatment of this medicine notably in later period of treatment of spit of fland of gas of A. American Dana - uncle, cancer research institute and researcher of the medical college of Harvard University of France, says on a new American " clinical oncological magazine ", they have analyzed about 4000 the breast cancer patient's data in later period in 5 clinical trials, 3 data of test issue at periodical that is appraise by counterpart through discussion already among them. The analysis result reveals, in accepting the breast cancer patient of the treatment of spit of fland of gas of A, 1.6% of the people decline the congestive heart in test, and only 0.4% of the people decline the congestive heart in the person who takes placebo. Tony of expert whom the leader studies easy Ari says: " all in all, (spit of fland of gas of A the one that improve the heart and decline) The risk is still relatively small, but is higher than the placebo group notably. " He thinks, this research has further initiated the worry to the spit of fland of gas of A. A gas spit of fland whether a resist blood vessel, turn into medicine, block blood supplt in tumour by inhibiting a skin growth factor in a blood vessel and contributing, make tumour unable to spread in the body, and impel chemotherapy to contribute effectively. American Food and Drug Administration is sanctioned the spit of fland of gas of A to use for treating breast cancer through the summary procedure in 2008, but require Luo's company to launch two follow-up study in order to confirm its curative effect. Before this, this kind of medicine is still in charge of American medicine in the office and sanction being used for treating lung cancer, cancer of colon and rectal cancer, and get permission to be used for treating breast cancer in Europe. Company, Luo of Switzerland, sell well anticancer drugs most as 2009, annual sales amount of spit of fland, gas of A, reach 5,900 million dollars. However, 4 clinical trials indicate, can not lengthen the breast cancer patient's life cycle in the spit of fland of gas of A. American medicine is in charge of office's proposing Luo's company from the manual of this medicine in December of 2010 " Indication " Remove in the column " Breast cancer " ,European medicine supervises the department and proposes limiting the scope of application of the spit of fland of gas of A too.


|